Neuramis | Endorsed by Renowned Actress "Son Ye-jin" - Newly Launched in Late 2023
 
         
         
             
             
             
             
                 
                 
                 
                 
                 
                 
               
               
               
               
               
               
               
               
               
               
            Neuramis Hyaluronic Acid, also known as Neuramis, developed by Korea's cosmetic giant Medytox and endorsed by famous actress Son Ye-jin, features the exclusive "SHAPE cross-linking technology". It combines safety, softness, support, naturalness, and high integration, now used in over 33 countries worldwide. Compared to other traditional hyaluronic acids, Neuramis focuses more on a "natural feel", offering a softer facial contour compared to other brands, ideal for those who prefer a naturally gentle beauty. Neuramis is suitable for facial depressions (e.g., cheeks, cheekbones, temples).
 
            Neuramis utilizes high-quality hyaluronic acid materials certified by FDA (DMF) and EDQM (European Directorate for the Quality of Medicines), with stringent processing standards to minimize residual proteins and endotoxins that could cause inflammatory reactions. All materials must meet standards higher than those required by the European Pharmacopoeia (Ph. Eur) to produce the highest quality and safest products.
 
               
            
              To enhance the support of hyaluronic acid, a cross-linking agent
              is essential. In Taiwan,
              legally marketed hyaluronic acid products use "BDDE" as the
                cross-linking agent. Although the cross-linker is metabolized over time and is
              harmless to the human body, the free cross-linker could
              potentially be carcinogenic. Thus,
              the industry standard requires BDDE residuals to be less than
                2ppm
              to avoid human harm. 
Medytox insists on standards
              where residuals are virtually undetectable, utilizing their
              exclusive "SHAPE cross-linking technology" to create stable
              hyaluronic acid links, making the purification process more
              efficient and
              minimizing BDDE residue.
            
 
            Neuramis uses high-quality hyaluronic acid materials certified by FDA (DMF) and EDQM (European Directorate for the Quality of Medicines), with high processing standards. All materials must meet standards higher than those required by the European Pharmacopoeia (Ph. Eur) to produce the highest standard and safest products.
 
            Good tissue compatibility is key to achieving natural results post-injection! Under pathological sections, Neuramis shows good skin compatibility and tolerance, blending well with surrounding skin tissues to present a natural look. Additionally, Neuramis possesses both smooth and granular textures to effectively resist external forces and pressure, preventing deformation or displacement. Clinical evidence also shows that the response rate to Neuramis remains as high as 84% after two years.
Anticoagulants, aspirin, and similar drugs may cause more bruising or bleeding at the injection site; it's recommended to stop using them a week prior.
Pregnant or breastfeeding women, those allergic to lidocaine (anesthetic), should inform their doctor beforehand.
If you have a history of severe allergies or are allergic to any component of hyaluronic acid, please avoid injection.
Post-treatment icing can effectively reduce the chances of swelling and bruising.
Avoid strenuous exercise or high-temperature environments like saunas and hot springs within a week after hyaluronic acid injection.
It's recommended to enhance home moisturizing and soothing care after the treatment.
Hyaluronic acid is natural, with a very low chance of allergic or rejection reactions. Some may experience mild swelling, pain, itching, bruising, or a sense of foreign body, which typically eases within a few days post-injection.
The duration of Neuramis effects varies with individual physiology, post-treatment care, and lifestyle habits, lasting longer than standard hyaluronic acid, approximately 18-24 months.
Clinics apply anesthetic cream before injections, and Neuramis contains anesthetic, reducing discomfort during the procedure.
Immediate results are visible post-injection, with optimal appearance emerging about two weeks after swelling subsides at the injection sites.